… Lung Cancer Clinical Study Group Trial 2002 (HOT2002) was a retrospective, observational,
multicenter study conducted at 19 institutions in Japan. The objective of this study was to …

Full article: Hormone receptor status predicts the clinical outcome of human epidermal
growth factor 2-positive metastatic breast cancer patients receiving trastuzumab therapy: a …

… Expression of epidermal growth factor receptor (EGFR) is observed in 50–70% of colorectal
carcinoma and is associated with poor prognosis. The aim of this study was to determine the …

… ) with minor mutations in the epidermal growth factor receptor (EGFR) … The aim of the present
study was to describe the clinical … : This was a multicenter, retrospective study that analyzed …

… Hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) are of
prognostic and therapeutic value in evaluating breast cancer. The accurate detection of HR and …

… by epidermal growth factor receptor inhibitors and to explore the relationship between skin
… -small cell lung cancer receiving epidermal growth factor receptor inhibitors were retrieved …

… In this retrospective study, we investigated the clinicopathological features associated with
… Human epidermal growth factor-2 (HER2) protein overexpression or v-erb-b2 erythroblastic …

… receptor (HR) and human epidermal growth factor receptor 2 (HER2) status [2] along with
patient preference, prior therapy (and tolerability), comorbidities, and organ function [3]. …

… This multicenter retrospective medical chart review study was conducted at three Japanese
institutions and involved patients aged 75 years and above with epidermal growth factor …

… In the past, advanced breast cancer with positive Human Epidermal growth factor Receptor
2 (… (2) Methods: We performed a retrospective review of all breast cancer patients who were …